Position in BIIB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$557,441,929
+$93,033,534 QoQ
Shares Held
2,580,033
-2.2% QoQ
Ownership
1.75%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#9
of 1,037 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. BIIB ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in BIIB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $557,441,929 | 2,580,033 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $464,408,395 | 2,638,834 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $284,357,989 | 2,264,177 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $294,669,340 | 2,153,386 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $355,569,431 | 2,325,199 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $438,929,745 | 2,264,392 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $481,894,665 | 2,078,745 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $328,434,893 | 1,523,141 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $378,728,267 | 1,463,571 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $392,992,962 | 1,529,096 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $409,963,241 | 1,439,225 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $382,995,778 | 1,377,534 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $362,128,837 | 1,307,702 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $332,344,779 | 1,244,737 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $240,601,681 | 1,179,767 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $288,743,761 | 1,371,053 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $373,124,783 | 1,555,205 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $459,012,892 | 1,622,011 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $630,609,956 | 1,821,151 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $490,141,023 | 1,752,068 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $466,128,473 | 1,903,653 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $571,623,426 | 2,015,029 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $572,466,033 | 2,139,660 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $702,956,812 | 2,221,875 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||